Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome

Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome

The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.

Inclusion Criteria:

either

1. a requirement of either 200 mg of diazepam (or diazepam equivalents) in 4 hrs;
2. > 40mg of diazepam (or diazepam equivalents) in 1 hr; or
3. an individual dose of 40 mg or greater of intravenous diazepam for control of agitation

Exclusion Criteria:

• if < 18 years of age or had evidence of use of other illicit substances as determined by urine toxicology screen